Bernd Werle
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 16
- Immunology and Allergy top 5%
- Oncology top 10%
- Peptidase Inhibition and Analysis 7
- Bone health and treatments 4
- Nephrology top 10%
- Rheumatology top 10%
- Bone and Dental Protein Studies 2
-
- Bone Metabolism and Diseases 4
- Molecular Biology Techniques and Applications 3
-
- Advanced Proteomics Techniques and Applications 2
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 2
- Co-authors
- Janko KosTamara T. LahW. ÉbertEberhard SpießNils BrünnerKlaus KayserVito TürkNina Cimerman
- Partner nations
- GermanySloveniaUnited States
In The Last Decade
Bernd Werle
24 papers receiving 909 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 564
- Immunology and Allergy 103
- Oncology 265
- Nephrology 68
- Rheumatology 135
Countries citing papers authored by Bernd Werle
This map shows the geographic impact of Bernd Werle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Werle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Werle more than expected).
Fields of papers citing papers by Bernd Werle
This network shows the impact of papers produced by Bernd Werle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Werle. The network helps show where Bernd Werle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bernd Werle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 13 | |
| 2 | 2006 | 38 | |
| 3 | 2005 | 106 | |
| 4 | Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer. | 2005 | 53 |
| 5 | 2003 | 39 | |
| 6 | Expression, proliferation activity and clinical significance of cathepsin B and cathepsin L in operated lung cancer. | 2003 | 32 |
| 7 | Immunohistochemical analysis of cathepsin B and cathepsin S in tumors, parenchyma and regional lymph nodes of the lung | 2002 | 1 |
| 8 | 2001 | 44 | |
| 9 | 2001 | 78 | |
| 10 | 2000 | 48 | |
| 11 | 2000 | 33 | |
| 12 | 2000 | 2 | |
| 13 | 1999 | 44 | |
| 14 | 1999 | 30 | |
| 15 | 1997 | 49 | |
| 16 | 1997 | 30 | |
| 17 | Charge polymorphism in human lung cell pro-cathepsin B. | 1996 | 3 |
| 18 | 1995 | 42 | |
| 19 | 1995 | 32 | |
| 20 | 1994 | 31 |
About Bernd Werle
Bernd Werle is a scholar working on Cancer Research, Equine and Oncology, having authored 24 papers that have together received 938 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (16 papers), Peptidase Inhibition and Analysis (7 papers), Bone Metabolism and Diseases (4 papers), Bone health and treatments (4 papers), Molecular Biology Techniques and Applications (3 papers), Advanced Proteomics Techniques and Applications (2 papers), Bone and Dental Protein Studies (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Cancer Research (564 citations), Immunology and Allergy (103 citations) and Oncology (265 citations). Bernd Werle has collaborated with scholars based in Germany, Slovenia and United States. Frequent co-authors include Janko Kos, Tamara T. Lah, W. Ébert, Eberhard Spieß, Nils Brünner, Klaus Kayser, Vito Türk, Nina Cimerman, Magnus Abrahamson and W. Fiehn. Their work appears in journals such as British Journal of Cancer, Biological Chemistry, Cancer, Advances in experimental medicine and biology and Journal of Veterinary Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.